Novartis AG - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionBoston Partners
Latest Disclosed Ownership55,173 shares
Latest Disclosed Value $ 8,431,223
Boston Partners reports 16.63% increase in ownership of NVS / Novartis AG - Depositary Receipt (Common Stock)

On May 11, 2026 - Boston Partners filed a 13F-HR form disclosing ownership of 55,173 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $8,427,676 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 47,304 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 16.63% during the quarter. The current value of the position is $7,926,153 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 55,173 7,869 16.63 8,431 29.11 0.0038
2026-02-13 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 47,304 -7,239 -13.27 6,531 -6.87 0.0068
2025-11-13 2025-09-30 13F NOVARTIS SPONSORED ADR 66987V109 54,543 1,813 3.44 7,013 10.11 0.0072
2025-08-12 2025-06-30 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 52,730 11,247 27.11 6,369 37.72 0.0071
2025-08-07 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 52,730 11,247 6,369 0.0029
2025-05-13 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 41,483 -11,876 -22.26 4,624 -10.97 0.0056
2025-02-11 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 53,359 16,320 44.06 5,195 21.90 0.0063
2024-11-12 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 37,039 1,572 4.43 4,261 12.70 0.0050
2024-08-14 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 35,467 17,450 96.85 3,781 116.92 0.0047
2024-05-28 2024-03-31 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 18,017 -13,759 -43.30 1,743 -45.67 0.0021
2024-05-13 2024-03-31 13F NOVARTIS SPONSORED ADR 66987V109 18,017 -13,759 1,743 0.0009
2024-02-07 2023-12-31 13F NOVARTIS SPONSORED ADR 66987V109 31,776 1,836 6.13 3,208 5.21 0.0042
2023-11-08 2023-09-30 13F NOVARTIS SPONSORED ADR 66987V109 29,940 2,250 8.13 3,050 9.13 0.0042
2023-08-10 2023-06-30 13F NOVARTIS SPONSORED ADR 66987V109 27,690 0 0.00 2,794 9.70 0.0038
2023-05-09 2023-03-31 13F NOVARTIS SPONSORED ADR 66987V109 27,690 -2,410 -8.01 2,547 -6.70 0.0035
2023-02-08 2022-12-31 13F NOVARTIS SPONSORED ADR 66987V109 30,100 -1,742,349 -98.30 2,731 -97.98 0.0037
2022-11-09 2022-09-30 13F NOVARTIS SPONSORED ADR 66987V109 1,772,449 -2,811,869 -61.34 135,136 -65.14 0.1978
2022-08-10 2022-06-30 13F NOVARTIS SPONSORED ADR 66987V109 4,584,318 -25,857 -0.56 387,674 -4.27 0.5418
2022-05-10 2022-03-31 13F NOVARTIS SPONSORED ADR 66987V109 4,610,175 -67,228 -1.44 404,961 -1.03 0.4906
2022-02-04 2021-12-31 13F NOVARTIS SPONSORED ADR 66987V109 4,677,403 292,854 6.68 409,194 14.11 0.4929
2021-11-05 2021-09-30 13F NOVARTIS SPONSORED ADR 66987V109 4,384,549 -1,915,211 -30.40 358,605 -37.62 0.4543
2021-08-12 2021-06-30 13F NOVARTIS SPONSORED ADR 66987V109 6,299,760 439,189 7.49 574,844 14.70 0.7331
2021-05-10 2021-03-31 13F NOVARTIS SPONSORED ADR 66987V109 5,860,571 -190,564 -3.15 501,153 -12.30 0.6721
2021-02-10 2020-12-31 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 6,051,135 -227,345 -3.62 571,408 4.66 0.8887
2021-02-04 2020-12-31 13F NOVARTIS SPONSORED ADR 66987V109 6,051,135 -227,345 571,408 342,810.8364
2020-11-13 2020-09-30 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 6,278,480 -374,043 -5.62 545,977 -6.04 0.9942
2020-11-09 2020-09-30 13F NOVARTIS SPONSORED ADR 66987V109 6,652,523 0 581,049 426,559.1818
2020-08-12 2020-06-30 13F NOVARTIS SPONSORED ADR 66987V109 6,652,523 3,359,705 102.03 581,049 114.06 1.0672
2020-05-13 2020-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 3,292,818 1,560,022 90.03 271,448 65.43 0.5391
2020-02-06 2019-12-31 13F/A-1 NOVARTIS A G SPONSORED ADR 66987V109 1,732,796 -174,425 -9.15 164,082 -1.00 0.2170
2020-02-05 2019-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 1,732,796 -174,425 164,082 92,251.6927
2019-11-20 2019-09-30 13F/A-1 NOVARTIS A G SPONSORED ADR 66987V109 1,907,221 -2,015,339 -51.38 165,747 -53.72 0.2244
2019-11-08 2019-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 3,864,246 -58,314 352,787 0.4666
2019-08-26 2019-06-30 13F/A-1 NOVARTIS A G SPONSORED ADR 66987V109 3,922,560 -2,539,848 -39.30 358,106 -42.36 0.4696
2019-08-09 2019-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 3,922,706 -2,539,702 358,119
2019-05-13 2019-03-31 13F/A-1 NOVARTIS A G SPONSORED ADR 66987V109 6,462,408 -584,386 -8.29 621,296 2.75 0.8232
2019-05-03 2019-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 6,462,408 -584,386 621,296
2019-02-07 2018-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 7,046,794 1,459,845 26.13 604,685 25.62 0.8689
2018-11-14 2018-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 5,586,949 -19,681 -0.35 481,372 13.66 0.5594
2018-08-03 2018-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 5,606,630 2,885,436 106.04 423,525 92.50 0.5076
2018-05-04 2018-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 2,721,194 877,892 47.63 220,008 42.16 0.2653
2018-02-14 2017-12-31 13F/A-1 NOVARTIS A G SPONSORED ADR 66987V109 1,843,302 -14,133 -0.76 154,763 -2.95 0.1823
2018-02-01 2017-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 1,843,302 -14,133 154,763
2017-11-02 2017-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 1,857,435 240,573 14.88 159,461 18.15 0.1970
2017-08-02 2017-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 1,616,862 10,745 0.67 134,960 13.14 0.1716
2017-05-03 2017-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 1,606,117 48,465 3.11 119,286 5.13 0.1523
2017-02-06 2016-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 1,557,652 -232,957 -13.01 113,460 -19.75 0.1492
2016-11-09 2016-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 1,790,609 -20,434 -1.13 141,386 -5.38 0.1977
2016-08-05 2016-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 1,811,043 -175,142 -8.82 149,429 3.86 0.2159
2016-05-12 2016-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 1,986,185 -40,118 -1.98 143,879 -17.47 0.2119
2016-02-08 2015-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 2,026,303 167,543 9.01 174,343 2.04 0.2497
2015-11-10 2015-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 1,858,760 -67,446 -3.50 170,857 -9.80 0.2604
2015-08-10 2015-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 1,926,206 -40,339 -2.05 189,423 -2.32 0.2721
2015-05-05 2015-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 1,966,545 -333,438 -14.50 193,921 -9.01 0.2887
2015-02-09 2014-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 2,299,983 -61,218 -2.59 213,117 -4.11 0.3199
2014-11-12 2014-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 2,361,201 -56,586 -2.34 222,259 1.54 0.3607
2014-08-08 2014-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 2,417,787 -117,017 -4.62 218,882 1.57 0.3666
2014-05-07 2014-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 2,534,804 273,032 12.07 215,509 18.54 0.3931
2014-02-06 2013-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 2,261,772 2,261,772 181,801 0.3727
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.